25 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... 3 years • Co-testing ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Preventing and Treating ... Penicilliosis #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Preventing and Treating ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
Group A Strep Pharyngitis, also known as  Strep Throat. 

In addition to symptomatic presentation, a
antigen detection test ... recommended by IDSA ... That's because this test ... penicillin allergy testing ... #StrepThroat #Management
Disseminated Gonococcal Infection - Diagnosis and Management Summary

Bacteremic spread of the Gram-negative diplococci Neisseria gonorrhoeae. History
Diagnosis and Management ... susceptibility testing ... the preferred test ... the workup • Test ... Distal joints, knees
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Preventing and Treating ... Trypanosomiasis #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... candida #mucosal #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... every 21 days Treating ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... for Treating Herpes ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS